Pattern dystrophies in patients treated with deferoxamine. Report of two cases and review of the literature
Background: Deferoxamine (DFO) is one of the most commonly used chelation treatments for transfusional hemosiderosis. Pattern dystrophies constitute a distinct entity of retinal disorders that has been occasionally identified in association with deferoxamine. Case presentation: We report two cases...
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Journal (paper) |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-018-0911-2 http://hdl.handle.net/10889/12156 |